IntermediateGrowth StrategyHealthcare & Life SciencesBCG
Pharmaceutical Rare Disease Business Growth
Published March 7, 2025
Industry: Pharmaceuticals Case Type: Growth Strategy Difficulty: Medium Firm (if applicable): BCG
About this Case
Type:Growth Strategy
Difficulty:Intermediate
Industries:Healthcare & Life Sciences
Source:BCG
Published:March 7, 2025